# Houlihan Lokey, Inc.: financial statements, quarterly

HLI · NYSE · CIK 1302215 · [Financials](/sectors/financials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/hli.md) · [Financials](/companies/hli/financials.md) · [Filings](/companies/hli/filings.md) · [Insiders](/companies/hli/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hli/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [467](/filings/0001302215-24-000110.md) | [511](/filings/0001302215-25-000007.md) | [520 d](/filings/0001302215-26-000053.md) | [514](/filings/0001302215-25-000092.md) | [575](/filings/0001302215-25-000111.md) | [634](/filings/0001302215-26-000007.md) | [666 d](/filings/0001302215-26-000053.md) | [605](/filings/0001302215-26-000067.md) | [659](/filings/0001302215-25-000111.md) | [717](/filings/0001302215-26-000007.md) | [636 d](/filings/0001302215-26-000053.md) | [511](/filings/0001302215-26-000067.md) |
| Gross profit | $m | [143](/filings/0001302215-24-000110.md) | [151](/filings/0001302215-25-000007.md) | [157 d](/filings/0001302215-25-000024.md) | [157](/filings/0001302215-25-000092.md) | [190](/filings/0001302215-25-000111.md) | [199](/filings/0001302215-26-000007.md) | [226 d](/filings/0001302215-25-000024.md) | [188](/filings/0001302215-26-000067.md) | [223](/filings/0001302215-25-000111.md) | [231](/filings/0001302215-26-000007.md) | not reported | [154](/filings/0001302215-26-000067.md) |
| Operating income | $m | [90.3](/filings/0001302215-24-000110.md) | [96.5](/filings/0001302215-25-000007.md) | [113 d](/filings/0001302215-26-000053.md) | [94.7](/filings/0001302215-25-000092.md) | [131](/filings/0001302215-25-000111.md) | [136](/filings/0001302215-26-000007.md) | [141 d](/filings/0001302215-26-000053.md) | [90.0](/filings/0001302215-26-000067.md) | [151](/filings/0001302215-25-000111.md) | [161](/filings/0001302215-26-000007.md) | [125 d](/filings/0001302215-26-000053.md) | [78.0](/filings/0001302215-26-000067.md) |
| Income tax | $m | [26.5](/filings/0001302215-24-000110.md) | [31.8](/filings/0001302215-25-000007.md) | [37.0 d](/filings/0001302215-26-000053.md) | [10.9](/filings/0001302215-25-000092.md) | [42.5](/filings/0001302215-25-000111.md) | [49.8](/filings/0001302215-26-000007.md) | [28.3 d](/filings/0001302215-26-000053.md) | [0.0](/filings/0001302215-26-000067.md) | [48.3](/filings/0001302215-25-000111.md) | [53.1](/filings/0001302215-26-000007.md) | [36.2 d](/filings/0001302215-26-000053.md) | [8.0](/filings/0001302215-26-000067.md) |
| Net income | $m | [67.0](/filings/0001302215-24-000110.md) | [70.8](/filings/0001302215-25-000007.md) | [81.1 d](/filings/0001302215-26-000053.md) | [88.9](/filings/0001302215-25-000092.md) | [93.5](/filings/0001302215-25-000111.md) | [95.3](/filings/0001302215-26-000007.md) | [122 d](/filings/0001302215-26-000053.md) | [98.0](/filings/0001302215-26-000067.md) | [112](/filings/0001302215-25-000111.md) | [117](/filings/0001302215-26-000007.md) | [99.8 d](/filings/0001302215-26-000053.md) | [78.0](/filings/0001302215-26-000067.md) |
| Diluted EPS | $ per share | [0.99](/filings/0001302215-24-000110.md) | [1.04](/filings/0001302215-25-000007.md) | not reported | [1.30](/filings/0001302215-25-000092.md) | [1.37](/filings/0001302215-25-000111.md) | [1.39](/filings/0001302215-26-000007.md) | not reported | [1.42](/filings/0001302215-26-000067.md) | [1.63](/filings/0001302215-25-000111.md) | [1.70](/filings/0001302215-26-000007.md) | not reported | [1.15](/filings/0001302215-26-000067.md) |
| Basic EPS | $ per share | [1.04](/filings/0001302215-24-000110.md) | [1.10](/filings/0001302215-25-000007.md) | not reported | [1.37](/filings/0001302215-25-000092.md) | [1.42](/filings/0001302215-25-000111.md) | [1.45](/filings/0001302215-26-000007.md) | not reported | [1.47](/filings/0001302215-26-000067.md) | [1.67](/filings/0001302215-25-000111.md) | [1.75](/filings/0001302215-26-000007.md) | not reported | [1.17](/filings/0001302215-26-000067.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [494](/filings/0001302215-23-000089.md) | [556](/filings/0001302215-24-000005.md) | [721](/filings/0001302215-25-000024.md) | [450](/filings/0001302215-24-000090.md) | [691](/filings/0001302215-24-000110.md) | [799](/filings/0001302215-25-000007.md) | [971](/filings/0001302215-26-000053.md) | [794](/filings/0001302215-25-000092.md) | [924](/filings/0001302215-25-000111.md) | [1,056](/filings/0001302215-26-000007.md) | [1,189](/filings/0001302215-26-000067.md) | [745](/filings/0001302215-26-000067.md) |
| Total assets | $m | [2,782](/filings/0001302215-23-000089.md) | [2,959](/filings/0001302215-24-000005.md) | [3,171](/filings/0001302215-25-000024.md) | [2,943](/filings/0001302215-24-000090.md) | [3,213](/filings/0001302215-24-000110.md) | [3,476](/filings/0001302215-25-000007.md) | [3,820](/filings/0001302215-26-000053.md) | [3,518](/filings/0001302215-25-000092.md) | [3,793](/filings/0001302215-25-000111.md) | [3,937](/filings/0001302215-26-000007.md) | [4,309](/filings/0001302215-26-000067.md) | [3,717](/filings/0001302215-26-000067.md) |
| Total liabilities | $m | [1,135](/filings/0001302215-23-000089.md) | [1,190](/filings/0001302215-24-000005.md) | [1,334](/filings/0001302215-25-000024.md) | [1,113](/filings/0001302215-24-000090.md) | [1,256](/filings/0001302215-24-000110.md) | [1,395](/filings/0001302215-25-000007.md) | [1,645](/filings/0001302215-26-000053.md) | [1,340](/filings/0001302215-25-000092.md) | [1,546](/filings/0001302215-25-000111.md) | [1,643](/filings/0001302215-26-000007.md) | [1,856](/filings/0001302215-26-000067.md) | [1,352](/filings/0001302215-26-000067.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,646](/filings/0001302215-23-000089.md) | [1,769](/filings/0001302215-24-000005.md) | [1,837](/filings/0001302215-26-000053.md) | [1,829](/filings/0001302215-25-000111.md) | [1,957](/filings/0001302215-26-000007.md) | [2,081](/filings/0001302215-26-000007.md) | [2,175](/filings/0001302215-26-000067.md) | [2,178](/filings/0001302215-26-000067.md) | [2,247](/filings/0001302215-26-000007.md) | [2,294](/filings/0001302215-26-000007.md) | [2,342](/filings/0001302215-26-000067.md) | [2,255](/filings/0001302215-26-000067.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [136 d](/filings/0001302215-24-000110.md) | [101 d](/filings/0001302215-25-000007.md) | [225 d](/filings/0001302215-26-000053.md) | [(64.5)](/filings/0001302215-25-000092.md) | [289 d](/filings/0001302215-25-000111.md) | [266 d](/filings/0001302215-26-000007.md) | [358 d](/filings/0001302215-26-000053.md) | [(132)](/filings/0001302215-26-000067.md) | [325 d](/filings/0001302215-25-000111.md) | [218 d](/filings/0001302215-26-000007.md) | [293 d](/filings/0001302215-26-000053.md) | [(336)](/filings/0001302215-26-000067.md) |
| Capital expenditure | $m | [23.3 d](/filings/0001302215-24-000110.md) | [15.6 d](/filings/0001302215-25-000007.md) | [12.2 d](/filings/0001302215-26-000053.md) | [10.9](/filings/0001302215-25-000092.md) | [10.5 d](/filings/0001302215-25-000111.md) | [3.9 d](/filings/0001302215-26-000007.md) | [14.5 d](/filings/0001302215-26-000053.md) | [13.0](/filings/0001302215-26-000067.md) | [2.4 d](/filings/0001302215-25-000111.md) | [0.6 d](/filings/0001302215-26-000007.md) | [6.3 d](/filings/0001302215-26-000053.md) | [6.0](/filings/0001302215-26-000067.md) |
| Dividends paid | $m | [35.4 d](/filings/0001302215-24-000110.md) | [35.5 d](/filings/0001302215-25-000007.md) | [35.6 d](/filings/0001302215-26-000053.md) | [51.3](/filings/0001302215-25-000092.md) | [38.4 d](/filings/0001302215-25-000111.md) | [37.0 d](/filings/0001302215-26-000007.md) | [38.5 d](/filings/0001302215-26-000053.md) | [53.0](/filings/0001302215-26-000067.md) | [41.3 d](/filings/0001302215-25-000111.md) | [40.6 d](/filings/0001302215-26-000007.md) | [39.2 d](/filings/0001302215-26-000053.md) | [61.0](/filings/0001302215-26-000067.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [69.8](/filings/0001302215-23-000089.md) | [69.7](/filings/0001302215-24-000005.md) | [68.0](/filings/0001302215-24-000090.md) | [67.9](/filings/0001302215-24-000110.md) | [67.9](/filings/0001302215-25-000007.md) | [68.5](/filings/0001302215-25-000092.md) | [68.4](/filings/0001302215-25-000111.md) | [68.8](/filings/0001302215-26-000007.md) | [68.9](/filings/0001302215-26-000067.md) | [68.6](/filings/0001302215-25-000111.md) | [68.4](/filings/0001302215-26-000007.md) | [67.6](/filings/0001302215-26-000067.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.